Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
617.50    9.00 (1.48%)
Bid:
617.00
Ask:
618.00
Spread: 1.00 (0.162%)
Market Cap: £2.85b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

2022 AGM Vote Outcome Update Statement

13 Jan 2023 09:00

RNS Number : 6692M
RS Group PLC
13 January 2023
Β 

13 January 2023

RS GROUP PLC

2022 AGM VOTE OUTCOME UPDATE STATEMENT

RS Group plc (the "Company") today provides an update in respect of the results of its Annual General Meeting ("AGM") held on 14 July 2022. At the Company's AGM, all resolutions were duly passed by poll with the requisite majority. The Board notes that the resolution in respect of the Remuneration Policy received a vote of more than 20% against (as a percentage of total number of votes cast). The votes cast in favour of this resolution was 60.77%.

In advance of the 2022 AGM, the Company undertook an extensive multi-phased consultation process with over 20 major shareholders (representing around 80% of the register) in respect of the proposed changes to the Remuneration Policy, and in particular the one-off Journey to Greatness long-term incentive award ("J2G LTIP"). Through the consultation process, we received valuable feedback and insights from all those we spoke to, with much of this directly influencing the shape of the final proposals (for example - on the J2G LTIP performance measures framework). The shareholders who did raise concerns were primarily focused on the potential maximum quantum under the J2G LTIP and actions required to deliver the maximum pay out awards possible.

The Committee and the Board believe it is important to align the remuneration for our top leaders and the wider workforce with our high-performance, purpose-led culture and strategy and the outcomes experienced by all stakeholders. We firmly believe that the introduction of the J2G LTIP under the 2022 Remuneration Policy provides an effective framework to incentivise senior leadership to deliver truly exceptional performance which would deliver significant sustained and value creative growth and is right for our business and its stakeholders, including our people, customers and shareholders, at this stage in the Group's evolution. Whilst recognising that there are wider social sensitivities with regard to potential quantum, the Committee remains committed to ensuring that any payments under the J2G LTIP reflect the delivery of exceptional and very stretching stakeholder outcomes and retains the discretion to adjust awards if they are not deemed appropriate in the circumstances.

Further to the announcement made on 16 December 2022 regarding Lindsley Ruth stepping down as Chief Executive Officer, we have confirmed that all J2G LTIP awards held by Lindsley have lapsed in full.

We would like to thank shareholders that took part in the engagement process and value the feedback provided. As part of our ongoing commitment to open and ongoing dialogue, a follow up engagement process is being conducted, where shareholders have been offered the chance to further share perspectives on the Remuneration Policy and maintain a dialogue on investor attitudes to remuneration. A further update will be provided in the 2022/23 Directors' Remuneration Report.

Β 

Enquiries:

Lucy Sharma, VP Investor Relations

RS Group plc

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRBJMPTMTTBMIJ
Date   Source Headline
8th Jul 20264:20 pmRNSHolding(s) in Company
6th Jul 20267:00 amRNSTransaction in Own Shares
2nd Jul 20265:23 pmRNSHolding(s) in Company
1st Jul 20269:58 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 202610:00 amRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSAnnual Financial Report and Notice of AGM
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202610:00 amRNSDirector/PDMR Shareholding
2nd Jun 20263:55 pmRNSDirector Declaration
1st Jun 202612:43 pmRNSHolding(s) in Company
1st Jun 20269:44 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:01 amRNSCommencement of Share Buyback Programme
20th May 20267:00 amRNSFinal Results
1st Apr 20265:06 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSPre-Close Trading Update
3rd Mar 20267:00 amRNSAcquisition of BPX Group
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
12th Dec 20253:14 pmRNSDirectorate change
4th Dec 202510:00 amRNSDirector/PDMR Shareholding
20th Nov 20254:20 pmRNSReplacement Holding(s) in Company
20th Nov 20253:30 pmRNSHolding(s) in Company
7th Nov 20253:56 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSHalf-year Financial Report
1st Sep 20254:30 pmRNSHolding(s) in Company
12th Aug 20254:30 pmRNSHolding(s) in Company
8th Aug 20254:00 pmRNSHolding(s) in Company
1st Aug 202511:02 amRNSBlock listing Interim Review
21st Jul 20254:00 pmRNSDirector/PDMR Shareholding
17th Jul 20253:15 pmRNSResult of AGM
17th Jul 20257:00 amRNSAGM Update
4th Jul 202510:00 amRNSDirectorate Change - Chair of Audit Committee
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jun 20259:00 amRNSDirector/PDMR Shareholding
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
10th Jun 202511:00 amRNSHolding(s) in Company
9th Jun 202512:00 pmRNSAnnual Financial Report and Notice of AGM
6th Jun 20252:00 pmRNSDirector/PDMR Shareholding
29th May 202510:00 amRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSDirector/PDMR Shareholding
28th Mar 20252:30 pmRNSDirector/PDMR Shareholding
26th Mar 202511:00 amRNSDirector/PDMR Shareholding
21st Feb 202510:00 amRNSDirectorate Change
3rd Feb 202510:39 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNS3rd Quarter Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.